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Effect of Extracorporeal Life Support on Survival When Applied to 
All Patients With Congenital Diaphragmatic Hernia 
By Cynthia N. Steimle, Funda Merit, Ronald B. Hirschl, Mary Bozynski, Arnold G. Coran, and Robert H. Bartlett 
Ann Arbor, Michigan 
0 Extracorporeal life support (ECLS) has been used for 
neonates with congenital diaphragmatic hernia (CDH) and 
respiratory failure at the authors’ hospital since June 1981. In 
1988, criteria for inclusion in ECLS were broadened to include 
“nonhoneymoon” infants (honeymoon: best postductal Paor 
of >50 mm Hg). To evaluate the impact of this approach on 
the treatment of CDH, the authors reviewed the records of all 
newborns managed at their institution, since the availability 
of ECLS in 1981, who were symptomatic with CDH in the first 
24 hours of life (n = 111). The patients were divided chrono- 
logically into two groups: 1981 to 1987 (early ECLS, n = 38) 
and 1988 to 1993 (expanded ECLS, n = 75). The data demon- 
strate that the number of CDH patients managed at our 
institution each year has increased (1981 to 1987 = 8,1988 to 
1993 = 14) as has the severity of associated respiratory 
insufficiency (% of patients with best Paor of ~50 mm Hg: 
1981 to 1987 = 8%, 1988 to 1993 = 28%). Overall, the sur- 
vival rate was lower for patients in the expanded ECLS group 
(59% v 75%; P = .121). When the survival rates for patients 
supported with ECLS postoperatively were compared for the 
expanded and early groups, a significant difference (59% v 
80%; P < .05) was noted. However, when ECLS patients with 
a best Paor of 150 mm Hg were excluded from this analysis, 
there was no significant difference between the two groups 
(74% v 80%). indicating that the inclusion of nonhoneymoon 
patients as potential ECLS candidates has accounted for a 
significant portion of the observed decrease in survival 
among CDH patients managed with ECLS. The survival rate 
of salvageable CDH patients with a best Paor of 550 mm Hg 
increased slightly for the expanded ECLS group, to 27% (4 of 
15). versus 0% (0 of 2) for the early ECLS group. The authors 
conclude that a change in the population of CDH patients 
presenting to their institution along with application of ECLS 
to CDH patients without a honeymoon has resulted in a 
reduction in the survival rate, but has allowed only a modest 
27% survival rate for patients who were previously consid- 
ered nonsalvageable. 
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I N 1988, OUR GROUP reported an increase in the overall survival rate for infants with congenital 
diaphragmatic hernia (CDH), from 50% to 76%, 
through the application of extracorporeal life support 
(ECLS) in the setting of severe respiratory fai1ure.r 
At the time of our previous report, we commonly 
excluded patients from consideration for ECLS if 
they had never had a best postductal Pao2 of more 
than 50 mm Hg. It was believed that these patients 
had severe pulmonary hypoplasia, which would pre- 
clude recovery despite prolonged courses of ECLS. 
However, subsequent studies suggested that such 
criteria were nonspecific in predicting mortality and 
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not appropriate for use as ECLS exclusion criteria.2 
Therefore, in 1988, all patients with CDH who had 
persistent respiratory failure despite maximal conven- 
tional support were considered candidates for ECLS, 
provided their weight was more than 2 kg, their 
gestational age was more than 34 weeks, and they had 
no severe genetic anomalies or other abnormalities 
that would preclude viable existence. Herein we 
summarize our experience over the last 12 years, 
since ECLS has been available, and analyze the effect 
of such changes in ECLS selection criteria. 
MATERIALS AND METHODS 
We performed a retrospective review of the records of all 
patients with CDH treated at the University of Michigan Medical 
Center (UMMC), C.S. Mott Children’s Hospital. from June 1981 
to June 1993. 
Before 1981, ECLS therapy was not available at our center for 
the management of CDH patients with severe pulmonary failure. 
Subsequent to 1981, all patients who had significant respiratory 
failure despite maximal therapy with conventional ventilatory and 
pharmacological support were considered for ECLS. Criteria that, 
on retrospective review, could reliably identify infants with pro- 
jected mortality rates of 80% to 100% with conventional ventilatory 
support were used to select patients for treatment with ECLS.3.4 
The inclusion criteria include (1) acute deterioration, with Pao: of 
less than 40 mm Hg or pH of less than 7.15 for more than 2 hours: 
(2) oxygen index (01) of more than 40 on three of five measure- 
ments between 30 and 60 minutes apart (where 01 = FIO~ x mean 
airway pressure x 100, divided by postductal Paoz); or (3) severe 
barotrauma. Previously reported exclusion criteria were developed 
to eliminate patients from consideration for ECLS if reasonable 
expectation of meaningful survival could not be achieved.’ The 
exclusion criteria were (1) age of more than 10 days; (2) gestational 
age of less than 35 weeks; (3) weight of less than 2 kg; (4) 
preexisting severe intracranial hemorrhage; (5) serious coexistent 
genetic anomaly; (6) uncorrectable cyanotic heart disease; (7) 
moribund condition: or (8) ongoing cardiopulmonary resuscitation 
before cannulation was begun. In our initial experience, patients 
were excluded from consideration for ECLS if they never had a 
postductal Paoa of more than 50 mm Hg (ie. if they never had 
“honeymoon” period). This exclusion criterion was applied to 
identify “unsalvageable” patients with bilateral pulmonary hypopla- 
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sia. However, beginning in 1988, this exclusion criterion was no 
longer applied, and ECLS was then used in nonhoneymoon 
patients. Therefore, two eras, or groups, each with individual 
management strategies for CDH, were identified at our institution. 
Group 1 patients were treated from June 1981 to December 1987 
(“early ECLS era”). Group 2 patients were treated from January 
1988 to June 1993 (“expanded ECLS era”). 
An additional difference in management strategy between the 
early and expanded ECLS groups lies in the timing of operative 
repair. Before 1988, all patients were operated on as soon as it was 
feasible; ECLS was used only in the postoperative period. When 
we expanded our criteria for ECLS, it was noted that newborns 
with severe respiratory insufficiency would not be able to tolerate 
surgery unless bypass was initiated preoperatively. Therefore, we 
began to institute ECLS in these neonates emergently, and the 
operation was performed while they were on ECLS support. More 
recently, in 1993, we began to attempt to wean these patients from 
ECLS support before operative repair. Therefore, all ECLS 
patients in group 1 had repair before ECLS, but patients in group 2 
could be repaired pre-ECLS, on ECLS, or post-ECLS. 
The two groups of patients were assessed for differences in 
severity of illness and differences in survival rates. Data were 
compared using Fisher’s exact test and x2 analysis. 
RESULTS 
Between June 1981 and June 1993, 111 patients 
with CDH diagnosed in the first 24 hours of life were 
treated at the University of Michigan, C.S. Mott 
Children’s Hospital. Thirty-six of them were treated 
from June 1981 to December 1987 (early ECLS era; 
group l), and 75 were treated from January 1988 to 
June 1993 (expanded ECLS era; group 2). Therefore, 
the number of CDH patients managed each year at 
our institution increased from 6 per year (1981 to 
1987) to 14 per year (1988 to 1993) over the study 
period. 
Twenty-six of the 36 patients (72%) in the early 
ECLS group were born at outlying hospitals; seven of 
whom (27%) underwent operative repair before be- 
ing transferred to our facility. In the current ex- 
panded ECLS era, 52 of 75 (70%) were born at 
outlying hospitals, 16 of whom (31%) had repair 
before transport. 
Between the time periods, there was a substantial 
increase in the proportion of patients for whom the 
diagnosis was made in utero. In the early ECLS era, 
eight patients were identified as having CDH based 
on prenatal ultrasound examination (8 of 36; 22%); 
seven of these patients were delivered at our institu- 
tion. In group 2,30 patients had the diagnosis made in 
utero (30 of 75; 40%); 20 of them were delivered at 
our institution. Another 14 patients in this group had 
undergone prenatal ultrasound examination, and 
CDH had not been detected. 
As seen in Table 1, there were no significant 
differences between the two groups in terms of 
gestational age or birth weight. There was also no 
significant difference in the percentage of patients 
Table 1. Patient Characteristics 
Characteristic Early ECLS Expanded ECLS P 
No. of patients 
Gestational age (wk) 




Born at UMMC 
Repair at UMMC 
Diagnosis in utero 
Required ECLS 
Pao, 5 50 mm Hg 
36 
38.3 ? 2.8 










38.0 ? 2.9 



















with associated anomalies or in the percentage who 
had a left-sided hernia. The proportion of patients 
who met criteria for and in whom ECLS was used 
increased with time, as did the proportion of CDH 
patients who required a muscle flap or prosthetic 
reconstruction of the diaphragm at the time of CDH 
repair. In addition, the proportion of patients with a 
best Pao2 of I 50 mm Hg increased substantially (6% 
for the early ECLS group, 28% for the expanded 
ECLS group). 
The survival rates appear in Table 2. In the early 
ECLS group, overall survival was 27 of 36 (75%). Of 
the 27, 20 were treated postoperatively with conven- 
tional ventilation alone, and 15 survived (75%). In 
addition, 12 of 15 patients treated postoperatively 
with ECLS survived (80%). Of the six patients who 
died without the use of ECLS, two were excluded 
because their best Paoz did not exceed 50 mm Hg, two 
because of genetic anomalies, and two because of 
prematurity. 
In the expanded ECLS group, overall survival was 
44 of 75 (59%). Seventeen of the 44 were treated with 
conventionalventilation alone, and 15 survived (88%). 
The total number of patients treated with ECLS was 
49; of these, 29 survived (59%). These survival rates 
are lower than those for the early ECLS group; 
however, the difference was not significant (Fig 1). 
Twenty-nine patients had repair before initiation of 
ECLS, with 21 survivors (72%). Seventeen patients 
had repair while on ECLS, with six survivors (35%). 
Table 2. Survival Data 
Group Early ECLS Expanded ECLS P 
All patients 
All potential ECLS patients 
Pao, > 50 mm Hg, viable 
Pao, 5 50 mm Hg, viable 
ECLS, Pao, z 50 mm Hg 
All ECLS-treated patients 
36 (75) 75 (59) NS 
32 (84) 65 (67) NS 
30 (90) 50 (80) NS 
2 (0) 15 (27) NS 
15 (80) 34 (74) NS 
15 (80) 49 (59) <.05 
NOTE. Numbers in parentheses are percentages. 












Fig 1. Survival rates for patients with CDH. No statistically signifi- 
cant differences are seen between each era. “Viable” patients (shaded 
bars) are those who met inclusion criteria for ECLS. Solid bars denote 
all patients. 
Three patients were weaned from ECLS before CDH 
repair was attempted, with two survivors (67%). 
The extension of ECLS to patients with more 
severe respiratory failure clearly diminished survival 
in the group treated with ECLS. In the expanded 
ECLS group, there were 21 patients with a best 
postductal Paoz of 150. However, only 15 were 
placed on ECLS; the remainder were excluded by 
other criteria. Four of these survived (27%). These 
patients would have been excluded from ECLS under 
our previous criteria. There was a significant differ- 
ence in the survival rates between patients managed 
with ECLS in the expanded era and those managed in 
the early era (59% v 80%; P < .05). However, when 
only the patients whose best Paoz exceeded 50 mm 
Hg (managed with ECLS) were considered, there was 
no significant difference between the survival rates 
(80% for the early group, 74% for the expanded 
group). The period of time on ECLS for patients 
whose best Paoz was I 50 mm Hg was 14.5 + 7.1 days; 
this is significantly different from that of patients with 
a best Paoz of more than 50 mm Hg (9.9 + 6.5 days; 
P < .05). The average hospital stay for the four 
survivors whose best Pao2 was 550 mm Hg was 2 
months (range, 31 to 99 days). The mean period of 
hospitalization did not differ significantly between 
these patients and those whose best Pao2 exceeded 50 
mm Hg (52 ? 31 days v 49 -c 51 days). Follow-up of 
these four survivors (at 18 to 30 months) showed that 
one died at home of unknown causes a few months 
after hospital discharge. One required a fundoplica- 
tion for gastroesophageal reflux (GER), but is other- 
wise well. One child is slightly delayed neurologically 
and has reactive airway disease. This patient also had 
findings of GER and underwent a fundoplication 
procedure. The fourth child is normal. None of the 
three surviving patients currently requires supplemen- 
tal oxygen. 
It is interesting to note that the patients for whom 
CDH was diagnosed in utero in the early ECLS era all 
had a best Paoz of more than 50 mm Hg, and their 
overall survival rate was 75% (six of eight). However, 
for the expanded ECLS group, only 17 of 30 (57%) 
had a best Pao? of more than 50 mm Hg, with an 
overall survival rate of 37% (11 of 30). 
Seventeen patients had CDH repair while on 
ECLS support; there were six survivors (35%) in the 
expanded ECLS era. Ten of the 17 had a best Paoz of 
I 50 mm Hg; four of the 10 survived. Figure 2 shows 
the survival data for the patients repaired before and 
during ECLS. 
The incidence of significant complications during 
ECLS was low in both eras. Major bleeding was the 
most common complication, occurring in four pa- 
tients in the early era (26%) and four in the expanded 
era (8%). In the expanded era, three children were 
removed from ECLS because of severe intracranial 
hemorrhage. A fourth child had severe postoperative 
bleeding, which required discontinuation of ECLS; 
that child subsequently died of respiratory insuffi- 
ciency. There were no other complications of ECLS 
that directly contributed to patient death. In addition, 
there were no mechanical complications of ECLS 
that resulted in patient death. 
In the early ECLS era, there were nine deaths. Six 
of the nine children who died were excluded from 
ECLS support; two of these were premature, two had 
genetic anomalies, and two did not have a postductal 
Paoz of more than 50 mm Hg. One child died of 
intracranial hemorrhage while on ECLS support. The 
other two deaths occurred late-one secondary to 
REPAIRED BEFORE ECLS REPAIRED ON ECLS 
Fig 2. Expanded ECLS (1988-1993). Survival rates for patients 
treated with ECLS before or during CDH repair. Patients repaired 
while on ECLS had a significantly lower survival rate than those 
repaired before ECLS. 
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sepsis, and the other because of bronchopulmonary 
dysplasia (BPD). 
In the expanded ECLS era, there were 31 deaths. 
Ten occurred in patients who were excluded from 
ECLS support because of prematurity (4), multiple 
anomalies (3), pre-ECLS cardiac arrest (2), or intra- 
operative death (1). One death occurred late, in a 
child who had been transferred to another hospital 
for care; she died of acute onset of respiratory failure, 
which was attributed to BPD. The causes of death for 
the 20 patients managed with ECLS included persis- 
tent respiratory failure (7), bleeding complications 
(5), sequelae of ischemic neurological injury (3), 
necrotizing enterocolitis (2), and multisystem organ 
failure (3). All three in the latter group had had renal 
failure during ECLS. Two had concomitant persistent 
respiratory failure, but one had been successfully 
weaned from ECLS and died 12 days later, after the 
development of sepsis from acalculous cholecystitis. 
DISCUSSION 
Reports of survival of CDH patients published 
from 1965 to 1985 show mortality rates in the range of 
50%.’ The causes of death can be grouped as follows: 
(1) pulmonary hypoplasia, (2) persistent pulmonary 
hypertension of the newborn, and (3) associated 
anomalies.5 ECLS was introduced to support the 
neonate while persistent pulmonary hypertension 
resolves. 
Selection of patients for treatment with ECLS has 
been a topic of great debate. Multiple criteria have 
been developed by Bohn et al, Stolar et al, and others, 
which serve as predictors of high mortality in the 
CDH patient managed with conventional mechanical 
ventilation.6,7 However, although these various crite- 
ria appear to have relevance in terms of predicting 
those who will die with conventional support alone, 
the issue of which patients will succumb even if more 
aggressive intervention is instituted (such as ECLS) 
remains unresolved. Attempts to develop criteria that 
identify patients with inadequate lung parenchyma to 
support life have generally been unsuccessfu12,* Con- 
sequently, most centers have begun to offer ECLS 
support to any neonate with CDH for whom conven- 
tional mechanical ventilatory support has failed. 
In 1988, at our institution, we began to use ECLS 
support in any neonate for whom conventional me- 
chanical ventilatory support had failed. A review of 
our survival data since that time, as compared with 
our previous survival figures, indicates that overall 
survival has diminished since the change was insti- 
tuted (59% v 75%), although this difference is not 
statistically significant. In addition, the survival rate 
for all patients managed with ECLS decreased signifi- 
cantly between the early and expanded eras, whereas 
the survival rate for those whose best Pao2 exceeded 
50 mm Hg has not decrease significantly. These data 
allow us to conclude that it is the inclusion of these 
more severely affected newborns that has accounted 
for the major portion of the observed decrease in 
survival among patients managed with ECLS. Expan- 
sion of criteria to include CDH patients with a best 
Paoz of 150 mm Hg has resulted in only a small 
(27%) increase in survival among the patients who 
were previously considered unsalvageable. As is evi- 
dent from the long courses on ECLS and the pro- 
longed hospital stay for survivors, considerable re- 
sources are expended in an attempt to salvage very 
few patients. We believe that patients with a best 
Pao, of 150 mm Hg remain relatively poor candi- 
dates for ECLS and that each center should evaluate 
whether their experience in this high-mortality group 
warrants the continued inclusion of such patients as 
ECLS candidates. 
The number of cases diagnosed in utero has in- 
creased dramatically, from eight (22%) in the early 
ECLS era to 30 (44%) in the expanded era. All eight 
of the early patients had a best Pao2 of more than 50 
mm Hg; only three required ECLS support, and six of 
the eight (75%) survived. In contrast, in the expanded 
era, only 17 of 30 (57%) had a best Pao2 of more than 
50 mm Hg, and survival was only 11 of 30 (37%). It is 
evident that the recent application of in utero ultraso- 
nography has led to an increase in the severity of 
respiratory insufficiency of CDH patients managed at 
our institution. We suggest that this is because of 
changes in perinatal referral patterns, which have led 
to more expeditious and efficient transfer, either 
before or after birth, of the fetus/newborn with 
known CDH. In utero diagnosis is also responsible for 
the increase in referrals to our institution (from 36 
patients in the early era to 75 in the expanded era). 
The timing of surgical repair for infants with CDH 
has been a subject of recent debate. Traditionally, 
emergency surgical repair of CDH has been per- 
formed to reduce the herniated viscera, to eliminate 
the risk of bowel incarceration, and to eliminate 
compression of the lungs and resultant poor gas 
exchange. However, surgical repair of CDH has been 
shown to result in a reduction in pulmonary compli- 
ance.9 In already marginally ventilating infants, this 
decreased compliance can have severe clinical conse- 
quences. Bohn et al suggested that delayed surgical 
repair might allow reversal of pulmonary artery hyper- 
tension and improved survival6 However, some in- 
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fants are not able to oxygenate and ventilate ad- condition are maintained in the neonatal intensive 
equately at the time of initial presentation. Our care unit and are electively repaired before extuba- 
current protocol allows placement of such infants on tion, usually when they are at least 72 hours of age. 
ECLS, with delay in operative repair until the pa- The effect of this approach on the outcome of 
tients can be successfully weaned from ECLS sup- newborns with CDH managed at our institution is yet 
port. Infants who present to our center in stable to be determined. 
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Discussion 
K. Lally (Houston, TX): The authors have nicely 
shown that if entry criteria for ECMO in patients with 
diaphragmatic hernia are expanded, survival not 
unexpectedly decreases. Certainly, increasing the in- 
born population would give you a high number of 
these very high-risk patients. In the most recent series 
of your patients, you had 23 in-born and 52 out-born 
patients. I’d like to know, did you have any difference 
in survival between these two groups? 
Secondly, almost every predictor of nonsurvival 
published to date has not truly withstood the test of 
time, although there is growing consensus that the 
inability to ventilate by preductal Pcoz may reflect 
inadequate alveolar surface area and be a reasonable 
predictor. Did any of your survivors have a best 
preductal Pcoz of greater than 50? 
And finally, improvement in survival with ECLS 
has led to growing recognition of the long-term 
problems with CDH survivors, including late deaths 
from right-sided heart failure, gastroesophageal re- 
flux, and recurrent herniation. Do you have any late 
follow-up information for your ECLS survivors? 
C.N. Steimle (response): We did not see any differ- 
ence in outcome between the in-born and out-born 
groups. We believe this is probably because the ability 
to treat the patients quickly when they are in-born is 
balanced by the fact that we also do see sicker 
patients who, had they been out-born, would have 
never made it to our center for therapy. 
We did not routinely measure the best Pco2 until 
about a year ago. We are now looking at this as one of 
our predictors of mortality. We’re also looking at other 
indicators of mortality, including left ventricular mass. 
In the follow-up of the four surviving patients, who 
had a best Paoz of less than 50, there was one late 
death; however, the other three patients are doing 
well, are functionally intact, and have no significant 
problems. 
